Skip to content

Planning for Your Drug Development Success: From the Bench to the Clinic

Google Video

Loading...
Loading...

Planning for Your Drug Development Success: From the Bench to the Clinic

 

 

Date: February 2, 2010
Time: 11:30AM-2:00PM 
Venue: San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Registration Cost: from $0 to $40
The discovery and identification of a new molecular entity (NME) and the application of research required to show a proof-of-principle for a therapeutic agent can be rife with pitfalls and it is extremely difficult to qualify a new prospect for venture funding or partnering with another pharmaceutical company. This event will include discussions around: • Leveraging Drug Metabolism and Pharmacokinetics in Lead Selection and PreClinical Therapeutic Development • Moving From Research To Development: Avoiding The Pitfalls • Effective Partnering with a Contract Research Organization to Optimize Your Drug Development Plan • The Role of Preclinical Safety Assessment in the Drug Development Process. The session will conclude with a panel discussion to provide attendees with the opportunity for valuable exchanges with experts in the fields of drug development and regulatory toxicology. | Registration fee: from $0 to $40 | 11:30-2:00 | @ the San Jose BioCenter, 5941 Optical Court, San Jose CA 95138

Speakers: Dr. David Brewster, VP and Sr. Safety Expert for Global NonClinical Safety, F. Hoffman-La Roche | Dr. Richard Slauter, Senior Director of Drug Metabolism and Pharmacokinetics, MPI Research, Inc. | Dr. Brian Rogers, VP of Toxicology, Pacific BioDevelopment | Dr. Stephen Frantz, Senior Director of Business Development, Pacific Northwest, MPI Research, Inc.

 

Luminogenics is a resource with interests in systems of technology commercialization in the life sciences. Included here is a directory of hundreds of biotech incubators, research parks, and associations.



Powered by Drupal, an open source content management system
AdaptiveThemes